APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

In Vivo Pharmacology Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global In Vivo Pharmacology Service Industry Growth and Trends Forecast to 2032

Report ID 17416112012 May 2026124 pages

Choose your research edition.

Industry ResearchIn Vivo Pharmacology Service Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal In Vivo Pharmacology Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal In Vivo Pharmacology Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In Vivo Pharmacology Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal In Vivo Pharmacology Service Market Analysis and Forecast 2026-2032183 pages · $4,950 USD

Market perspective

According to APO Research, the global In Vivo Pharmacology Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for In Vivo Pharmacology Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for In Vivo Pharmacology Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In Vivo Pharmacology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the In Vivo Pharmacology Service market include NuChem Sciences Inc, Eurofins Discovery, Oncodesign Services, Jubilant Biosys, Pharmaron, Melior Discovery, NUVISAN GmbH, Porsolt and Sygnature Discovery, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global In Vivo Pharmacology Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The In Vivo Pharmacology Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global In Vivo Pharmacology Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to In Vivo Pharmacology Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global In Vivo Pharmacology Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

In Vivo Pharmacology Service Market by Company

NuChem Sciences Inc

Eurofins Discovery

Oncodesign Services

Jubilant Biosys

Pharmaron

Melior Discovery

NUVISAN GmbH

Porsolt

Sygnature Discovery

Aurigene Pharmaceutical Services Ltd

Reaction Biology

Addexbio

Paraza Pharma, Inc

Aragen Life Sciences Ltd

Dalriada

Biocytogen

Charles River Laboratories

Pharmacelsu

HitGen Inc

TCG Lifesciences

In Vivo Pharmacology Service Segment by Type

Small Molecule Screening

Large Molecule Screening

Others

In Vivo Pharmacology Service Segment by Application

Neurological Diseases

Cardiovascular and Metabolic Diseases

Skin Diseases

Others

In Vivo Pharmacology Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vivo Pharmacology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vivo Pharmacology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vivo Pharmacology Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of In Vivo Pharmacology Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global In Vivo Pharmacology Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global In Vivo Pharmacology Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global In Vivo Pharmacology Service Market Share by Region (2021-2026) Table 4. Global In Vivo Pharmacology Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global In Vivo Pharmacology Service Market Share by Region (2027-2032) Table 6. Global In Vivo Pharmacology Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global In Vivo Pharmacology Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global In Vivo Pharmacology Service Market Size Share by Type (2021-2026) Table 9. Global In Vivo Pharmacology Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global In Vivo Pharmacology Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America In Vivo Pharmacology Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe In Vivo Pharmacology Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific In Vivo Pharmacology Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America In Vivo Pharmacology Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa In Vivo Pharmacology Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global In Vivo Pharmacology Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global In Vivo Pharmacology Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global In Vivo Pharmacology Service Market Size Share by Application (2021-2026) Table 24. Global In Vivo Pharmacology Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global In Vivo Pharmacology Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America In Vivo Pharmacology Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe In Vivo Pharmacology Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific In Vivo Pharmacology Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America In Vivo Pharmacology Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa In Vivo Pharmacology Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. In Vivo Pharmacology Service Industry Trends Table 37. In Vivo Pharmacology Service Industry Drivers Table 38. In Vivo Pharmacology Service Industry Opportunities and Challenges Table 39. In Vivo Pharmacology Service Industry Restraints Table 40. Global In Vivo Pharmacology Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global In Vivo Pharmacology Service Revenue Market Share by Company (2021-2026) Table 42. Global In Vivo Pharmacology Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global In Vivo Pharmacology Service Key Company Headquarters & Area Served Table 44. Global In Vivo Pharmacology Service Company, Product Type & Application Table 45. Global In Vivo Pharmacology Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global In Vivo Pharmacology Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. NuChem Sciences Inc Company Information Table 49. NuChem Sciences Inc Business Overview Table 50. NuChem Sciences Inc In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. NuChem Sciences Inc In Vivo Pharmacology Service Product Portfolio Table 52. NuChem Sciences Inc Recent Development Table 53. Eurofins Discovery Company Information Table 54. Eurofins Discovery Business Overview Table 55. Eurofins Discovery In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eurofins Discovery In Vivo Pharmacology Service Product Portfolio Table 57. Eurofins Discovery Recent Development Table 58. Oncodesign Services Company Information Table 59. Oncodesign Services Business Overview Table 60. Oncodesign Services In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Oncodesign Services In Vivo Pharmacology Service Product Portfolio Table 62. Oncodesign Services Recent Development Table 63. Jubilant Biosys Company Information Table 64. Jubilant Biosys Business Overview Table 65. Jubilant Biosys In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Jubilant Biosys In Vivo Pharmacology Service Product Portfolio Table 67. Jubilant Biosys Recent Development Table 68. Pharmaron Company Information Table 69. Pharmaron Business Overview Table 70. Pharmaron In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pharmaron In Vivo Pharmacology Service Product Portfolio Table 72. Pharmaron Recent Development Table 73. Melior Discovery Company Information Table 74. Melior Discovery Business Overview Table 75. Melior Discovery In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Melior Discovery In Vivo Pharmacology Service Product Portfolio Table 77. Melior Discovery Recent Development Table 78. NUVISAN GmbH Company Information Table 79. NUVISAN GmbH Business Overview Table 80. NUVISAN GmbH In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. NUVISAN GmbH In Vivo Pharmacology Service Product Portfolio Table 82. NUVISAN GmbH Recent Development Table 83. Porsolt Company Information Table 84. Porsolt Business Overview Table 85. Porsolt In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Porsolt In Vivo Pharmacology Service Product Portfolio Table 87. Porsolt Recent Development Table 88. Sygnature Discovery Company Information Table 89. Sygnature Discovery Business Overview Table 90. Sygnature Discovery In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sygnature Discovery In Vivo Pharmacology Service Product Portfolio Table 92. Sygnature Discovery Recent Development Table 93. Aurigene Pharmaceutical Services Ltd Company Information Table 94. Aurigene Pharmaceutical Services Ltd Business Overview Table 95. Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Product Portfolio Table 97. Aurigene Pharmaceutical Services Ltd Recent Development Table 98. Reaction Biology Company Information Table 99. Reaction Biology Business Overview Table 100. Reaction Biology In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Reaction Biology In Vivo Pharmacology Service Product Portfolio Table 102. Reaction Biology Recent Development Table 103. Addexbio Company Information Table 104. Addexbio Business Overview Table 105. Addexbio In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Addexbio In Vivo Pharmacology Service Product Portfolio Table 107. Addexbio Recent Development Table 108. Paraza Pharma, Inc Company Information Table 109. Paraza Pharma, Inc Business Overview Table 110. Paraza Pharma, Inc In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Paraza Pharma, Inc In Vivo Pharmacology Service Product Portfolio Table 112. Paraza Pharma, Inc Recent Development Table 113. Aragen Life Sciences Ltd Company Information Table 114. Aragen Life Sciences Ltd Business Overview Table 115. Aragen Life Sciences Ltd In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Aragen Life Sciences Ltd In Vivo Pharmacology Service Product Portfolio Table 117. Aragen Life Sciences Ltd Recent Development Table 118. Dalriada Company Information Table 119. Dalriada Business Overview Table 120. Dalriada In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Dalriada In Vivo Pharmacology Service Product Portfolio Table 122. Dalriada Recent Development Table 123. Biocytogen Company Information Table 124. Biocytogen Business Overview Table 125. Biocytogen In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Biocytogen In Vivo Pharmacology Service Product Portfolio Table 127. Biocytogen Recent Development Table 128. Charles River Laboratories Company Information Table 129. Charles River Laboratories Business Overview Table 130. Charles River Laboratories In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Charles River Laboratories In Vivo Pharmacology Service Product Portfolio Table 132. Charles River Laboratories Recent Development Table 133. Pharmacelsu Company Information Table 134. Pharmacelsu Business Overview Table 135. Pharmacelsu In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Pharmacelsu In Vivo Pharmacology Service Product Portfolio Table 137. Pharmacelsu Recent Development Table 138. HitGen Inc Company Information Table 139. HitGen Inc Business Overview Table 140. HitGen Inc In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. HitGen Inc In Vivo Pharmacology Service Product Portfolio Table 142. HitGen Inc Recent Development Table 143. TCG Lifesciences Company Information Table 144. TCG Lifesciences Business Overview Table 145. TCG Lifesciences In Vivo Pharmacology Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. TCG Lifesciences In Vivo Pharmacology Service Product Portfolio Table 147. TCG Lifesciences Recent Development Table 148. North America In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America In Vivo Pharmacology Service Market Size by Country (2021-2026) & (US$ Million) Table 150. North America In Vivo Pharmacology Service Market Share by Country (2021-2026) Table 151. North America In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America In Vivo Pharmacology Service Market Share Forecast by Country (2027-2032) Table 153. Europe In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe In Vivo Pharmacology Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe In Vivo Pharmacology Service Market Share by Country (2021-2026) Table 156. Europe In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe In Vivo Pharmacology Service Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific In Vivo Pharmacology Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific In Vivo Pharmacology Service Market Share by Country (2021-2026) Table 161. Asia-Pacific In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific In Vivo Pharmacology Service Market Share Forecast by Country (2027-2032) Table 163. Latin America In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America In Vivo Pharmacology Service Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America In Vivo Pharmacology Service Market Share by Country (2021-2026) Table 166. Latin America In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America In Vivo Pharmacology Service Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa In Vivo Pharmacology Service Market Share by Country (2021-2026) Table 171. Middle East & Africa In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa In Vivo Pharmacology Service Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. In Vivo Pharmacology Service Product Image Figure 3. Global In Vivo Pharmacology Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global In Vivo Pharmacology Service Market Size (2021-2032) & (US$ Million) Figure 5. Global In Vivo Pharmacology Service Market Share by Region: 2025 VS 2032 Figure 6. Global In Vivo Pharmacology Service Market Share by Region (2021-2032) Figure 7. North America In Vivo Pharmacology Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe In Vivo Pharmacology Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific In Vivo Pharmacology Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America In Vivo Pharmacology Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa In Vivo Pharmacology Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Small Molecule Screening Image Figure 13. Global Small Molecule Screening Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Large Molecule Screening Image Figure 15. Global Large Molecule Screening Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global In Vivo Pharmacology Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global In Vivo Pharmacology Service Market Share by Type 2025 VS 2032 Figure 20. North America In Vivo Pharmacology Service Market Size Share by Type (2021-2032) Figure 21. Europe In Vivo Pharmacology Service Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific In Vivo Pharmacology Service Market Size Share by Type (2021-2032) Figure 23. Latin America In Vivo Pharmacology Service Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa In Vivo Pharmacology Service Market Size Share by Type (2021-2032) Figure 25. Neurological Diseases Image Figure 26. Global Neurological Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Cardiovascular and Metabolic Diseases Image Figure 28. Global Cardiovascular and Metabolic Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Skin Diseases Image Figure 30. Global Skin Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global In Vivo Pharmacology Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global In Vivo Pharmacology Service Market Share by Application 2025 VS 2032 Figure 35. North America In Vivo Pharmacology Service Market Size Share by Application (2021-2032) Figure 36. Europe In Vivo Pharmacology Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific In Vivo Pharmacology Service Market Size Share by Application (2021-2032) Figure 38. Latin America In Vivo Pharmacology Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa In Vivo Pharmacology Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 In Vivo Pharmacology Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America In Vivo Pharmacology Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America In Vivo Pharmacology Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America In Vivo Pharmacology Service Market Share by Country (2021-2032) Figure 45. Europe In Vivo Pharmacology Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe In Vivo Pharmacology Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe In Vivo Pharmacology Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific In Vivo Pharmacology Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific In Vivo Pharmacology Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific In Vivo Pharmacology Service Market Share by Country (2021-2032) Figure 51. Latin America In Vivo Pharmacology Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America In Vivo Pharmacology Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America In Vivo Pharmacology Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa In Vivo Pharmacology Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa In Vivo Pharmacology Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa In Vivo Pharmacology Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule Screening
  • Large Molecule Screening
  • Others
Applications
  • Neurological Diseases
  • Cardiovascular and Metabolic Diseases
  • Skin Diseases
  • Others
Companies covered
  • NuChem Sciences Inc
  • Eurofins Discovery
  • Oncodesign Services
  • Jubilant Biosys
  • Pharmaron
  • Melior Discovery
  • NUVISAN GmbH
  • Porsolt
  • Sygnature Discovery
  • Aurigene Pharmaceutical Services Ltd
  • Reaction Biology
  • Addexbio
  • Paraza Pharma, Inc
  • Aragen Life Sciences Ltd
  • Dalriada
  • Biocytogen
  • Charles River Laboratories
  • Pharmacelsu
  • HitGen Inc
  • TCG Lifesciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global In Vivo Pharmacology Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global In Vivo Pharmacology Service Market Size by Region (2021-2032)
  5. 1.4.1 Global In Vivo Pharmacology Service Market Size by Region (2021-2026)
  6. 1.4.2 Global In Vivo Pharmacology Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions In Vivo Pharmacology Service Market Size (2021-2032)
  8. 1.5.1 North America In Vivo Pharmacology Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe In Vivo Pharmacology Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific In Vivo Pharmacology Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America In Vivo Pharmacology Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa In Vivo Pharmacology Service Market Size Growth Rate (2021-2032)
2 In Vivo Pharmacology Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Small Molecule Screening
  3. 2.1.2 Large Molecule Screening
  4. 2.1.3 Others
  5. 2.2 Global In Vivo Pharmacology Service Market Size by Type
  6. 2.2.1 Global In Vivo Pharmacology Service Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global In Vivo Pharmacology Service Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global In Vivo Pharmacology Service Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global In Vivo Pharmacology Service Market Size by Regions
  10. 2.3.1 North America In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa In Vivo Pharmacology Service Market Size Breakdown by Type (2021-2026)
3 In Vivo Pharmacology Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Neurological Diseases
  3. 3.1.2 Cardiovascular and Metabolic Diseases
  4. 3.1.3 Skin Diseases
  5. 3.1.4 Others
  6. 3.2 Global In Vivo Pharmacology Service Market Size by Application
  7. 3.2.1 Global In Vivo Pharmacology Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global In Vivo Pharmacology Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global In Vivo Pharmacology Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global In Vivo Pharmacology Service Market Size by Regions
  11. 3.3.1 North America In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa In Vivo Pharmacology Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 In Vivo Pharmacology Service Industry Trends
  2. 4.2 In Vivo Pharmacology Service Industry Drivers
  3. 4.3 In Vivo Pharmacology Service Industry Opportunities and Challenges
  4. 4.4 In Vivo Pharmacology Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by In Vivo Pharmacology Service Revenue (2021-2026)
  2. 5.2 Global In Vivo Pharmacology Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global In Vivo Pharmacology Service Key Company Headquarters & Area Served
  4. 5.4 Global In Vivo Pharmacology Service Company, Product Type & Application
  5. 5.5 Global In Vivo Pharmacology Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global In Vivo Pharmacology Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 In Vivo Pharmacology Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 In Vivo Pharmacology Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 NuChem Sciences Inc
  2. 6.1.1 NuChem Sciences Inc Company Information
  3. 6.1.2 NuChem Sciences Inc Business Overview
  4. 6.1.3 NuChem Sciences Inc In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 NuChem Sciences Inc In Vivo Pharmacology Service Product Portfolio
  6. 6.1.5 NuChem Sciences Inc Recent Developments
  7. 6.2 Eurofins Discovery
  8. 6.2.1 Eurofins Discovery Company Information
  9. 6.2.2 Eurofins Discovery Business Overview
  10. 6.2.3 Eurofins Discovery In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eurofins Discovery In Vivo Pharmacology Service Product Portfolio
  12. 6.2.5 Eurofins Discovery Recent Developments
  13. 6.3 Oncodesign Services
  14. 6.3.1 Oncodesign Services Company Information
  15. 6.3.2 Oncodesign Services Business Overview
  16. 6.3.3 Oncodesign Services In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Oncodesign Services In Vivo Pharmacology Service Product Portfolio
  18. 6.3.5 Oncodesign Services Recent Developments
  19. 6.4 Jubilant Biosys
  20. 6.4.1 Jubilant Biosys Company Information
  21. 6.4.2 Jubilant Biosys Business Overview
  22. 6.4.3 Jubilant Biosys In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Jubilant Biosys In Vivo Pharmacology Service Product Portfolio
  24. 6.4.5 Jubilant Biosys Recent Developments
  25. 6.5 Pharmaron
  26. 6.5.1 Pharmaron Company Information
  27. 6.5.2 Pharmaron Business Overview
  28. 6.5.3 Pharmaron In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pharmaron In Vivo Pharmacology Service Product Portfolio
  30. 6.5.5 Pharmaron Recent Developments
  31. 6.6 Melior Discovery
  32. 6.6.1 Melior Discovery Company Information
  33. 6.6.2 Melior Discovery Business Overview
  34. 6.6.3 Melior Discovery In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Melior Discovery In Vivo Pharmacology Service Product Portfolio
  36. 6.6.5 Melior Discovery Recent Developments
  37. 6.7 NUVISAN GmbH
  38. 6.7.1 NUVISAN GmbH Company Information
  39. 6.7.2 NUVISAN GmbH Business Overview
  40. 6.7.3 NUVISAN GmbH In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 NUVISAN GmbH In Vivo Pharmacology Service Product Portfolio
  42. 6.7.5 NUVISAN GmbH Recent Developments
  43. 6.8 Porsolt
  44. 6.8.1 Porsolt Company Information
  45. 6.8.2 Porsolt Business Overview
  46. 6.8.3 Porsolt In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Porsolt In Vivo Pharmacology Service Product Portfolio
  48. 6.8.5 Porsolt Recent Developments
  49. 6.9 Sygnature Discovery
  50. 6.9.1 Sygnature Discovery Company Information
  51. 6.9.2 Sygnature Discovery Business Overview
  52. 6.9.3 Sygnature Discovery In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sygnature Discovery In Vivo Pharmacology Service Product Portfolio
  54. 6.9.5 Sygnature Discovery Recent Developments
  55. 6.10 Aurigene Pharmaceutical Services Ltd
  56. 6.10.1 Aurigene Pharmaceutical Services Ltd Company Information
  57. 6.10.2 Aurigene Pharmaceutical Services Ltd Business Overview
  58. 6.10.3 Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Product Portfolio
  60. 6.10.5 Aurigene Pharmaceutical Services Ltd Recent Developments
  61. 6.11 Reaction Biology
  62. 6.11.1 Reaction Biology Company Information
  63. 6.11.2 Reaction Biology Business Overview
  64. 6.11.3 Reaction Biology In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Reaction Biology In Vivo Pharmacology Service Product Portfolio
  66. 6.11.5 Reaction Biology Recent Developments
  67. 6.12 Addexbio
  68. 6.12.1 Addexbio Company Information
  69. 6.12.2 Addexbio Business Overview
  70. 6.12.3 Addexbio In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Addexbio In Vivo Pharmacology Service Product Portfolio
  72. 6.12.5 Addexbio Recent Developments
  73. 6.13 Paraza Pharma, Inc
  74. 6.13.1 Paraza Pharma, Inc Company Information
  75. 6.13.2 Paraza Pharma, Inc Business Overview
  76. 6.13.3 Paraza Pharma, Inc In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Paraza Pharma, Inc In Vivo Pharmacology Service Product Portfolio
  78. 6.13.5 Paraza Pharma, Inc Recent Developments
  79. 6.14 Aragen Life Sciences Ltd
  80. 6.14.1 Aragen Life Sciences Ltd Company Information
  81. 6.14.2 Aragen Life Sciences Ltd Business Overview
  82. 6.14.3 Aragen Life Sciences Ltd In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Aragen Life Sciences Ltd In Vivo Pharmacology Service Product Portfolio
  84. 6.14.5 Aragen Life Sciences Ltd Recent Developments
  85. 6.15 Dalriada
  86. 6.15.1 Dalriada Company Information
  87. 6.15.2 Dalriada Business Overview
  88. 6.15.3 Dalriada In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Dalriada In Vivo Pharmacology Service Product Portfolio
  90. 6.15.5 Dalriada Recent Developments
  91. 6.16 Biocytogen
  92. 6.16.1 Biocytogen Company Information
  93. 6.16.2 Biocytogen Business Overview
  94. 6.16.3 Biocytogen In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Biocytogen In Vivo Pharmacology Service Product Portfolio
  96. 6.16.5 Biocytogen Recent Developments
  97. 6.17 Charles River Laboratories
  98. 6.17.1 Charles River Laboratories Company Information
  99. 6.17.2 Charles River Laboratories Business Overview
  100. 6.17.3 Charles River Laboratories In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Charles River Laboratories In Vivo Pharmacology Service Product Portfolio
  102. 6.17.5 Charles River Laboratories Recent Developments
  103. 6.18 Pharmacelsu
  104. 6.18.1 Pharmacelsu Company Information
  105. 6.18.2 Pharmacelsu Business Overview
  106. 6.18.3 Pharmacelsu In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Pharmacelsu In Vivo Pharmacology Service Product Portfolio
  108. 6.18.5 Pharmacelsu Recent Developments
  109. 6.19 HitGen Inc
  110. 6.19.1 HitGen Inc Company Information
  111. 6.19.2 HitGen Inc Business Overview
  112. 6.19.3 HitGen Inc In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 HitGen Inc In Vivo Pharmacology Service Product Portfolio
  114. 6.19.5 HitGen Inc Recent Developments
  115. 6.20 TCG Lifesciences
  116. 6.20.1 TCG Lifesciences Company Information
  117. 6.20.2 TCG Lifesciences Business Overview
  118. 6.20.3 TCG Lifesciences In Vivo Pharmacology Service Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 TCG Lifesciences In Vivo Pharmacology Service Product Portfolio
  120. 6.20.5 TCG Lifesciences Recent Developments
7 North America
  1. 7.1 North America In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America In Vivo Pharmacology Service Market Size by Country (2021-2026)
  3. 7.3 North America In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe In Vivo Pharmacology Service Market Size by Country (2021-2026)
  3. 8.3 Europe In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific In Vivo Pharmacology Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America In Vivo Pharmacology Service Market Size by Country (2021-2026)
  3. 10.3 South America In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa In Vivo Pharmacology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa In Vivo Pharmacology Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst